-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Lowered to $158.00 at Canaccord Genuity Group
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective reduced by research analysts at Canaccord Genuity Group from $163.00 to $158.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 47.33% […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective reduced by research analysts at Canaccord Genuity Group from $163.00 to $158.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 47.33% […]
